55.00 - AOD-9604 - Research Peptide AOD-9604 is a modified peptide fragment of human growth hormone (HGH), studied for its potential in fat metabolism and regenerative applications
Medical Necessity Checklist for Formulary Exception If you're requesting a formulary exception, gather this documentation first: Required Documentation for Exception Request Current BMI documentation (30 or 27 with comorbidity) Documented comorbidities with ICD-10 codes: Obesity Class I/II/III (E66.811, E66.812, E66.813) Hypertension (I10) Type 2 Diabetes (E11) Dyslipidemia (E78.5) Obstructive Sleep Apnea (G47.33) Failed alternative treatments documented trials of: Phentermine or diethylpropion Qsymia or Contrave Semaglutide (Wegovy/Ozempic) for 6+ months Lifestyle modification records (diet/exercise program participation) Weight history showing chronic obesity (past 1-2 years) Letter of Medical Necessity from your Kaiser provider For more on prior auth documentation, see our Zepbound prior auth checklist EXCEPTION PATHWAYS How Some Members Get Coverage While standard coverage is limited, some Kaiser members do get Zepbound covered
As GLP-1 use expands across metabolic care, we examine how diagnosis and treatment patterns are shifting among patients newly diagnosed with one of the most common endocrine disorders in women of reproductive age
[DOI] [PMC free article] [PubMed] [Google Scholar] 98.Whitaker G.M., Lynn F.C., McIntosh C.H., Accili E.A
The rectal route puts KPV directly at the site of distal colonic inflammation, which aligns with the PepT1 uptake data
